Company Filing History:
Years Active: 2025
Title: The Innovations of Patrick Samuel Lown
Introduction
Patrick Samuel Lown is an accomplished inventor based in Minneapolis, MN. He has made significant contributions to the field of biotechnology, particularly in the development of affibody proteins. His work focuses on creating innovative solutions that can enhance medical imaging and therapeutic applications.
Latest Patents
Lown holds a patent for "Affibody proteins specific for B7-H3 (CD276)." This patent includes affibody polypeptides that specifically bind to B7-H3 with high affinity. The affibodies can be conjugated to contrast agents, such as microbubbles, for use in contrast-enhanced ultrasound imaging. This innovation has the potential to improve diagnostic capabilities in medical settings.
Career Highlights
Patrick Samuel Lown is affiliated with the University of Minnesota, where he conducts research and develops his inventions. His work has garnered attention for its potential applications in the medical field, particularly in cancer diagnostics and treatment.
Collaborations
Lown has collaborated with notable colleagues, including Lotfi Abou-Elkacem and Juergen Karl Willmann. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Patrick Samuel Lown is a notable inventor whose work in affibody proteins is paving the way for advancements in medical imaging and treatment. His contributions to biotechnology reflect a commitment to innovation and improving healthcare outcomes.